Search

Your search keyword '"Kapadia, Samir R."' showing total 2,597 results
Start Over Author "Kapadia, Samir R."
2,597 results on '"Kapadia, Samir R."'

252. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement

Author

Kapadia, Samir R., primary, Makkar, Raj, additional, Leon, Martin, additional, Abdel-Wahab, Mohamed, additional, Waggoner, Thomas, additional, Massberg, Steffen, additional, Rottbauer, Wolfgang, additional, Horr, Samuel, additional, Sondergaard, Lars, additional, Karha, Juhana, additional, Gooley, Robert, additional, Satler, Lowell, additional, Stoler, Robert C., additional, Messé, Steven R., additional, Baron, Suzanne J., additional, Seeger, Julia, additional, Kodali, Susheel, additional, Krishnaswamy, Amar, additional, Thourani, Vinod H., additional, Harrington, Katherine, additional, Pocock, Stuart, additional, Modolo, Rodrigo, additional, Allocco, Dominic J., additional, Meredith, Ian T., additional, and Linke, Axel, additional

Published
2022
Full Text
View/download PDF

254. Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients With Versus Without Mitral Annular Calcium

Author

Lak, Hassan Mehmood, primary, Chawla, Sanchit, additional, Gajulapalli, Rama D., additional, Verma, Beni R., additional, Ahmed, Taha, additional, Agrawal, Ankit, additional, Kumar, Sachin, additional, Alkhalaileh, Feras, additional, Ghimire, Bindesh, additional, Shekhar, Shashank, additional, Gad, Mohamed, additional, Bansal, Agam, additional, Layoun, Habib, additional, Nair, Raunak, additional, Yun, James, additional, Unai, Shinya, additional, Pettersson, Gösta B., additional, Reed, Grant W., additional, Puri, Rishi, additional, Krishnaswamy, Amar, additional, Harb, Serge C., additional, and Kapadia, Samir R., additional

Published
2022
Full Text
View/download PDF

269. Current Society of Thoracic Surgeons Model Reclassifies Mortality Risk in Patients Undergoing Transcatheter Aortic Valve Replacement

Author

Kumar, Arnav, Sato, Kimi, Narayanswami, Jyoti, Banerjee, Kinjal, Andress, Krystof, Lokhande, Chetan, Mohananey, Divyanshu, Anumandla, Anil Kumar, Khan, Abdur Rahman, Sawant, Abhishek C., Menon, Vivek, Krishnaswamy, Amar, Tuzcu, E. Murat, Jaber, Wael A., Mick, Stephanie, Svensson, Lars G., and Kapadia, Samir R.

Published
2018
Full Text
View/download PDF

270. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate use criteria for the treatment of patients with severe aortic stenosis: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons

Author

Bonow, Robert O, Brown, Alan S, Gillam, Linda D, Kapadia, Samir R, Kavinsky, Clifford J, Lindman, Brian R, Mack, Michael J, Thourani, Vinod H, Dehmer, Gregory J, Bonow, Robert O, Lindman, Brian R, Beaver, Thomas M, Bradley, Steven M, Carabello, Blase A, Desai, Milind Y, George, Isaac, Green, Philip, Holmes, David R, Jr, Johnston, Douglas, Leipsic, Jonathon, Mick, Stephanie L, Passeri, Jonathan J, Piana, Robert N, Reichek, Nathaniel, Ruiz, Carlos E, Taub, Cynthia C, Thomas, James D, Turi, Zoltan G, Doherty, John U, Dehmer, Gregory J, Bailey, Steven R, Bhave, Nicole M, Brown, Alan S, Daugherty, Stacie L, Dean, Larry S, Desai, Milind Y, Duvernoy, Claire S, Gillam, Linda D, Hendel, Robert C, Kramer, Christopher M, Lindsay, Bruce D, Manning, Warren J, Mehrotra, Praveen, Patel, Manesh R, Sachdeva, Ritu, Wann, L Samuel, Winchester, David E, and Allen, Joseph M

Published
2018
Full Text
View/download PDF

273. Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance.

Author

Kai Ming Wang, Tom, Kocyigit, Duygu, Choi, Harry, Anthony, Chris M., Chan, Nicholas, Bullen, Jennifer, Popović, Zoran B., Kapadia, Samir R., Krishnaswamy, Amar, Griffin, Brian P., Flamm, Scott D., Tang, W. H. Wilson, and Kwon, Deborah H.

Abstract

BACKGROUND: The severity classification of functional mitral regurgitation (FMR) remains controversial despite adverse prognosis and rapidly evolving interventions. Furthermore, it is unclear if quantitative assessment with cardiac magnetic resonance can provide incremental risk stratification for patients with ischemic cardiomyopathy (ICM) or non-ICM (NICM) in terms of FMR and late gadolinium enhancement (LGE). We evaluated the impact of quantitative cardiac magnetic resonance parameters on event-free survival separately for ICM and NICM, to assess prognostic FMR thresholds and interactions with LGE quantification. METHODS: Patients (n=1414) undergoing cardiac magnetic resonance for cardiomyopathy (ejection fraction<50%) assessment from April 1, 2001 to December 31, 2017 were evaluated. The primary end point was all-cause death, heart transplant, or left ventricular assist device implantation during follow-up. Multivariable Cox analyses were conducted to determine the impact of FMR, LGE, and their interactions with event-free survival. RESULTS: There were 510 primary end points, 395/782 (50.5%) in ICM and 114/632 (18.0%) in NICM. Mitral regurgitationfraction per 5% increase was independently associated with the primary end point, hazards ratios (95% CIs) of 1.04 (1.01-1.07; P=0.034) in ICM and 1.09 (1.02-1.16; P=0.011) in NICM. Optimal mitral regurgitation-fraction threshold for moderate and severe FMR were =20% and =35%, respectively, in both ICM and NICM, based on the prediction of the primary outcome. Similarly, optimal LGE thresholds were =5% in ICM and =2% in NICM. Mitral regurgitation-fraction×LGE emerged as a significant interaction for the primary end point in ICM (P=0.006), but not in NICM (P=0.971). CONCLUSIONS: Mitral regurgitation-fraction and LGE are key quantitative cardiac magnetic resonance biomarkers with differential associations with adverse outcomes in ICM and NICM. Optimal prognostic thresholds may provide important clinical risk prognostication and may further facilitate the ability to derive selection criteria to guide therapeutic decision-making. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

276. Two‐year outcomes after transcatheter aortic valve‐in‐valve implantation in degenerated surgical valves

Author

Abushouk, Abdelrahman I., primary, Abdelfattah, Omar, additional, Gad, Mohamed M., additional, Saad, Anas, additional, Hariri, Essa, additional, Isogai, Toshiaki, additional, Shekhar, Shashank, additional, Reed, Grant W., additional, Puri, Rishi, additional, Yun, James, additional, Vargo, Patrick R., additional, Weiss, Aaron J., additional, Burns, Daniel, additional, Unai, Shinya, additional, Popovic, Zoran, additional, Harb, Serge C., additional, Krishnaswamy, Amar, additional, Svensson, Lars G., additional, Johnston, Douglas R., additional, and Kapadia, Samir R., additional

Published
2022
Full Text
View/download PDF

277. Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use

Author

Lowenstern, Angela, primary, Hung, Anna, additional, Manandhar, Pratik, additional, Wegermann, Zachary K., additional, Kapadia, Samir R., additional, Lindman, Brian R., additional, Goel, Kashish, additional, Levack, Melissa, additional, Barker, Colin M., additional, Reed, Shelby D., additional, Cohen, David J., additional, and Vemulapalli, Sreekanth, additional

Published
2022
Full Text
View/download PDF

281. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement

Author

Isogai, Toshiaki, primary, Vanguru, Husitha Reddy, additional, Krishnaswamy, Amar, additional, Agrawal, Ankit, additional, Spilias, Nikolaos, additional, Shekhar, Shashank, additional, Saad, Anas M., additional, Verma, Beni Rai, additional, Puri, Rishi, additional, Reed, Grant W., additional, Popović, Zoran B., additional, Unai, Shinya, additional, Yun, James J., additional, Uchino, Ken, additional, and Kapadia, Samir R., additional

Published
2022
Full Text
View/download PDF

285. National Trends and Outcomes of Surgical Aortic Valve Replacement With Concomitant Mitral Valve Surgery

Author

Arshad, Hassaan Bin, primary, Minhas, Abdul Mannan Khan, additional, Khan, Safi U., additional, Nasir, Khurram, additional, Rao, Neha, additional, Thacker, Sameer, additional, Butt, Sara Ayaz, additional, Faza, Nadeen, additional, Little, Stephen H., additional, von Ballmoos, Moritz Wyler, additional, Kleiman, Neal S., additional, Reardon, Michael J., additional, Kapadia, Samir R., additional, and Goel, Sachin S., additional

Published
2022
Full Text
View/download PDF

290. Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation: Insights From a Large Multicenter Registry

Author

Ribeiro, Henrique B., Webb, John G., Makkar, Raj R., Cohen, Mauricio G., Kapadia, Samir R., Kodali, Susheel, Tamburino, Corrado, Barbanti, Marco, Chakravarty, Tarun, Jilaihawi, Hasan, Paradis, Jean-Michel, de Brito, Fabio S., Jr., Cánovas, Sergio J., Cheema, Asim N., de Jaegere, Peter P., del Valle, Raquel, Chiam, Paul T.L., Moreno, Raúl, Pradas, Gonzalo, Ruel, Marc, Salgado-Fernández, Jorge, Sarmento-Leite, Rogerio, Toeg, Hadi D., Velianou, James L., Zajarias, Alan, Babaliaros, Vasilis, Cura, Fernando, Dager, Antonio E., Manoharan, Ganesh, Lerakis, Stamatios, Pichard, Augusto D., Radhakrishnan, Sam, Perin, Marco Antonio, Dumont, Eric, Larose, Eric, Pasian, Sergio G., Nombela-Franco, Luis, Urena, Marina, Tuzcu, E. Murat, Leon, Martin B., Amat-Santos, Ignacio J., Leipsic, Jonathon, and Rodés-Cabau, Josep

Published
2013
Full Text
View/download PDF

296. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement

Author

Kapadia, Samir R., Makkar, Raj, Leon, Martin, Abdel-Wahab, Mohamed, Waggoner, Thomas, Massberg, Steffen, Rottbauer, Wolfgang, Horr, Samuel, Sondergaard, Lars, Karha, Juhana, Gooley, Robert, Satler, Lowell, Stoler, Robert C., Messé, Steven R., Baron, Suzanne J., Seeger, Julia, Kodali, Susheel, Krishnaswamy, Amar, Thourani, Vinod H., Harrington, Katherine, Pocock, Stuart, Modolo, Rodrigo, Allocco, Dominic J., Meredith, Ian T., Linke, Axel, Kapadia, Samir R., Makkar, Raj, Leon, Martin, Abdel-Wahab, Mohamed, Waggoner, Thomas, Massberg, Steffen, Rottbauer, Wolfgang, Horr, Samuel, Sondergaard, Lars, Karha, Juhana, Gooley, Robert, Satler, Lowell, Stoler, Robert C., Messé, Steven R., Baron, Suzanne J., Seeger, Julia, Kodali, Susheel, Krishnaswamy, Amar, Thourani, Vinod H., Harrington, Katherine, Pocock, Stuart, Modolo, Rodrigo, Allocco, Dominic J., Meredith, Ian T., and Linke, Axel

Abstract

BACKGROUND Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral embolic protection (CEP) may reduce the risk of stroke. METHODS We randomly assigned patients with aortic stenosis in a 1:1 ratio to undergo transfemoral TAVR with CEP (CEP group) or without CEP (control group). The primary end point was stroke within 72 hours after TAVR or before discharge (whichever came first) in the intention-to-treat population. Disabling stroke, death, transient ischemic attack, delirium, major or minor vascular complications at the CEP access site, and acute kidney injury were also assessed. A neurology professional examined all the patients at baseline and after TAVR. RESULTS A total of 3000 patients across North America, Europe, and Australia underwent randomization; 1501 were assigned to the CEP group and 1499 to the control group. A CEP device was successfully deployed in 1406 of the 1489 patients (94.4%) in whom an attempt was made. The incidence of stroke within 72 hours after TAVR or before discharge did not differ significantly between the CEP group and the control group (2.3% vs. 2.9%; difference, -0.6 percentage points; 95% confidence interval, -1.7 to 0.5; P = 0.30). Disabling stroke occurred in 0.5% of the patients in the CEP group and in 1.3% of those in the control group. There were no substantial differences between the CEP group and the control group in the percentage of patients who died (0.5% vs. 0.3%); had a stroke, a transient ischemic attack, or delirium (3.1% vs. 3.7%); or had acute kidney injury (0.5% vs. 0.5%). One patient (0.1%) had a vascular complication at the CEP access site. CONCLUSIONS Among patients with aortic stenosis undergoing transfemoral TAVR, the use of CEP did not have a significant effect on the incidence of periprocedural stroke, but on the basis of the 95% confidence interval around this outcome, the results may not rul

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results